Registration Opening Soon for BOS Events 2025!

Dates for BOS Events 2025 are confirmed as 11th and 12th June for BOS Basel 2025 and 25th and 26th November for BOS Manchester 2025. Please find further details outlining provisional floor plans and pricing options at the event links provided. Note that we plan to open for registrations on Monday 4th November at 09.00 GMT.

The focus of these events is partnerships in R&D outsourcing with the primary scope being development-stage CMC outsourcing of Small Molecules, Biologics and New Therapeutic Entities.

We continue to evaluate the opportunity for digital events and resources, please look out for an announcement soon on this. We look forward to welcoming you and your colleagues to BOS Events! Please contact the Bio2Business team for further details.

Follow us on LinkedIn to see our latest announcements


Featured Company (BOS Manchester 2024)

Logo for Veranova
Veranova
Veranova is a global leader in the development and manufacturing of specialist and complex APIs for pharma and biotech customers. We have over 50 years of experience navigating the challenges of the global healthcare industry, and nurturing long-standing, trusted customer relationships. Operating within...
View profile

Featured Speaker (BOS Basel 2024)

photo of Dr fullName_2470

Process Development and Commercialization of Highly Potent APIs

Dr firstname_2470 lastname_2470, CHEM Division Manager, companyname_2470

ABSTRACT: Process development, commercialization and manufacturing of highly potent API’s presents significant challenges but it also represents a major opportunity for biotech companies looking to bring new treatments to patients. However, handling these HPAPI’s requires expertise, specific equipment and organizational and technical measures to ensure control of occupational exposure and to avoid cross-contamination to ensure operator safety as well as
patient safety.
This presentation aims to provide a comprehensive overview of the best
practices applied at Ardena, offering pharmaceutical... Click here to Read More